Theriva Biologics, Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect
Theriva Biologics, Inc. (TOVX) reported Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect of $61.10 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-16.
Discontinued › Cash Flow › Change in Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect · last filed 2022-03-16
- Theriva Biologics, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2021-03-31 was $70.66M.
- Theriva Biologics, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2020-03-31 was -$4.96M.
- Theriva Biologics, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for the quarter ending 2019-03-31 was -$4.22M.
- Theriva Biologics, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2021 was $61.10M.
- Theriva Biologics, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2020 was -$8.82M.
- Theriva Biologics, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2019 was -$13.87M, a 217.55% decline from fiscal 2018.
- Theriva Biologics, Inc. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), excluding exchange rate effect for fiscal 2018 was $11.80M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 3 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 6 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 9 month | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect 12 month |
|---|---|---|---|---|
| 2021-12-31 | $61.10M 10-K · filed 2022-03-16 | |||
| 2021-09-30 | $65.91M 10-Q · filed 2021-11-03 | |||
| 2021-06-30 | $68.06M 10-Q · filed 2021-08-05 | |||
| 2021-03-31 | $70.66M 10-Q · filed 2021-05-05 | |||
| 2020-12-31 | -$8.82M 10-K · filed 2022-03-16 | |||
| 2020-09-30 | -$9.04M 10-Q · filed 2021-11-03 | |||
| 2020-06-30 | -$6.99M 10-Q · filed 2021-08-05 | |||
| 2020-03-31 | -$4.96M 10-Q · filed 2021-05-05 | |||
| 2019-12-31 | -$13.87M 10-K · filed 2021-03-04 | |||
| 2019-09-30 | -$10.27M 10-Q · filed 2020-11-10 | |||
| 2019-06-30 | -$7.21M 10-Q · filed 2020-08-06 | |||
| 2019-03-31 | -$4.22M 10-Q · filed 2020-05-05 | |||
| 2018-12-31 | $11.80M 10-K · filed 2020-02-20 | |||
| 2018-09-30 | -$7.57M 10-Q · filed 2019-11-04 | |||
| 2018-06-30 | -$9.99M 10-Q · filed 2019-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |